[HTML][HTML] Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: new trends and future perspectives in cancer therapy
SM Meybodi, P Rezaei, N Faraji… - Journal of Functional …, 2023 - Elsevier
Hepatocellular carcinoma (HCC), as a common malignancy of the liver, is the second
leading cause of cancer-related death in the world and mostly occurs in patients with a …
leading cause of cancer-related death in the world and mostly occurs in patients with a …
Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: New trends and future perspectives in cancer therapy
SM Meybodi, P Rezaei, N Faraji… - Journal of Functional …, 2023 - agris.fao.org
Hepatocellular carcinoma (HCC), as a common malignancy of the liver, is the second
leading cause of cancer-related death in the world and mostly occurs in patients with a …
leading cause of cancer-related death in the world and mostly occurs in patients with a …
Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: new trends and future perspectives in cancer therapy.
SM Meybodi, P Rezaei, N Faraji, K Jamehbozorg… - 2023 - cabidigitallibrary.org
Hepatocellular carcinoma (HCC), as a common malignancy of the liver, is the second
leading cause of cancer-related death in the world and mostly occurs in patients with a …
leading cause of cancer-related death in the world and mostly occurs in patients with a …
[PDF][PDF] Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: New trends and future perspectives in cancer therapy
SM Meybodi, P Rezaei, N Faraji… - Journal of Functional …, 2023 - researchgate.net
Hepatocellular carcinoma (HCC), as a common malignancy of the liver, is the second
leading cause of cancerrelated death in the world and mostly occurs in patients with a …
leading cause of cancerrelated death in the world and mostly occurs in patients with a …
[PDF][PDF] Curcumin and its novel formulations for the treatment of hepatocellular carcinoma: New trends and future perspectives in cancer therapy
SM Meybodi, P Rezaei, N Faraji… - Journal of Functional …, 2023 - researchgate.net
Hepatocellular carcinoma (HCC), as a common malignancy of the liver, is the second
leading cause of cancerrelated death in the world and mostly occurs in patients with a …
leading cause of cancerrelated death in the world and mostly occurs in patients with a …